* Theratechnologies Inc TH.TO reported a quarterly
adjusted loss
of 8 cents per share for the quarter ended in November, higher
than the same quarter last year, when the company reported EPS
of -36 cents. The mean expectation of four analysts for the
quarter was for a loss of 24 cents per share. Wall Street
expected results to range from -79 cents to -3 cents per share.
* Revenue rose 9.5% to $23.45 million from a year ago;
analysts
expected $23.36 million.
* Theratechnologies Inc's reported EPS for the quarter was a
loss
of 8 cents.
* The company reported a quarterly loss of $2.76 million.
* Theratechnologies Inc shares had risen by 7.0% this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 6.7%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"
Wall Street's median 12-month price target for Theratechnologies
Inc is C$6.41
This summary was machine generated from LSEG data February 23 at
03:26 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Nov. 30 2023 -0.24 -0.08 Beat
Aug. 31 2023 -0.29 -0.03 Beat
May. 31 2023 -0.25 -0.40 Missed
Feb. 28 2023 -0.38 -0.44 Missed